PiafskyKMOgilvieRI. Dosage of theophylline in bronchial asthma. N Engl J Med1975; 492: 1218–22.
2.
ZwillichCWSuttonFDNeffTACohnWMMatthayMDWeinbergerMW. Theophylline-induced seizures in adults: Correlation with serum concentration. Ann Intern Med1975; 82: 784–7.
3.
WeinbergerMWMatthayRAGinchanskyEJChidseyCAPettyTL. Intravenous aminophylline dosage: Use of serum theophylline measurement for guidance. JAMA1976; 235: 2110–3.
4.
KordashTRVanDellenRGMcCallJT. Theophylline concentrations in asthmatic patients: After administration of aminophylline. JAMA1977; 238: 139–41.
5.
JacobsMHSeniorRMKesslerG.Clinical experience with theophylline: Relationships between dosage, serum concentration, and toxicity. JAMA1976; 255: 1983–6.
6.
KoupJRSchentagJJVanceJWKuritzkyPMPyszczynskiDRJuskoWJ. System for clinical pharmacokinetic monitoring of theophylline therapy. Am J Hosp Pharm1976; 33: 949–56.
7.
JuskoWJKoupJRVanceJWSchentagJJKuritzkyP.Intravenous theophylline therapy: Nomogram guidelines. Ann Intern Med1977; 86: 400–4.
8.
GibaldiMPerrierD.Drugs and the pharmaceutical sciences. Vol. 1 Pharmacokinetics. New York: Marcel Dekker, 1975: 28.
9.
MitenkoPAOgilvieRI. Pharmacokinetics of intravenous theophylline. Clin Pharmacol Ther1973; 14: 509–13.
10.
WellingPGLyonsLLCraigWATrochtaGA. Influence of diet and fluid on bioavailability of theophylline. Clin Pharmacol Ther1975; 17: 475–80.
11.
HendelesLWeinbergerMBighleyL.Absolute bioavailability of oral theophylline. Am J Hosp Pharm1977; 34: 525–7.
12.
SchumacherGW. Practical pharmacokinetic techniques for drug consultation and evaluation, 1: Use of dosage regimen calculations. Am J Hosp Pharm1972; 29: 474–84.
13.
GibaldiMPerrierD.Drugs and the pharmaceutical sciences. Vol. 1 — Pharmacokinetics. New York: Marcel Dekker, 1975: 110.
14.
GalPJuskoWJYurchakAMFranklinBA. Theophylline disposition in obesity. Clin Pharmacol Ther1978; 23: 438–44.
15.
JelliffeRWJelliffeSM. A computer program for estimation of creatinine levels, age, sex and weight. Math Biosci1972; 14: 17–24.